WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)KIDNEY CARE PARTNERS INC CO FEDERAL HEALTH POLICY STRATEGIES, founded in 2003, is a community nonprofit in the Diseases & Disorders sector that reported $1.9M in total revenue in fiscal year 2023. Revenue surged 32% from the prior year, signaling strong growth momentum. The organization ran a surplus of $422K, a strong 22% operating margin.
TO PROMOTE THE COMMON GOOD AND GENERAL WELFARE OF ALL AMERICANS BY 1)PROMOTING RESPONSIBLE GOVERNMENT PRACTICES THROUGH PUBLIC POLICIES THAT ASSURE HIGH QUALITY KIDNEY CARE TREATMENT FOR PEOPLE WHO HAVE ADVANCED KIDNEY DISEASE, 2)PROMOTING RESPONSIBLE AND EFFICIENT MEDICARE REFORM RELATING TO DIALYSIS AND TO ENSURE PATIENTS HAVE ACCESS TO QUALITY OF CARE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $1,947,138 | $1,473,804 | +0.3% |
| Expenses | $1,525,093 | $1,946,424 | -0.2% |
| Net Income | $422,045 | $-472,620 | -1.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| GENE BLANKENSHIP | DIALYSEDIRECT | 2.00 |
Director
|
$0 | $0 | $0 |
| BILL POIRIER | GREENFIELD HS | 2.00 |
Director
|
$0 | $0 | $0 |
| MO ALZUBAIDI | RENAL P.A. | 2.00 |
Director
|
$0 | $0 | $0 |
| STACEY FAHRNER | FRESENIUS M.C. | 2.00 |
Director
|
$0 | $0 | $0 |
| CHERILYN CEPRIANO | KC COUNCIL | 2.00 |
Director
|
$0 | $0 | $0 |
| CHRIS LEIBUNDGUTH | BAXTER INTL | 2.00 |
Director
|
$0 | $0 | $0 |
| SARAH HAMLETT | CSL VIFOR | 0.00 |
Director
|
$0 | $0 | $0 |
| DONNA BEDNARSKI | NEPHROLOGY NA | 2.00 |
Director
|
$0 | $0 | $0 |
| ERIN MISTRY | CORMEDIX INC | 2.00 |
Director
|
$0 | $0 | $0 |
| BABAJIDE SALAKO | DIALYSIS CARE | 2.00 |
Director
|
$0 | $0 | $0 |
| J GANESH BHAT | ATLANTIC DMS | 2.00 |
Director
|
$0 | $0 | $0 |
| DAN WEINER | A S NEPHROLOGY | 2.00 |
Director
|
$0 | $0 | $0 |
| GARY ROBINSON | CENTER DIALYSIS | 2.00 |
Director
|
$0 | $0 | $0 |
| JEFFREY SILBERZWEIG | ROGOSIN INSTITU | 2.00 |
Director
|
$0 | $0 | $0 |
| JOELLE THORNHILL | DAVITA INC | 2.00 |
Director
|
$0 | $0 | $0 |
| KATHY HOULE | NEPHROLOGY NURS | 2.00 |
Director
|
$0 | $0 | $0 |
| POOJA DESAI | ASTRAZENECA | 2.00 |
Director
|
$0 | $0 | $0 |
| LAVARNE BURTON | AMERICAN KIDNEY | 2.00 |
Director
|
$0 | $0 | $0 |
| CHRIS GOODWIN | GLAXOSMITHKLEIN | 0.00 |
Director
|
$0 | $0 | $0 |
| SHALABH GUPTA | UNICYCIVE THERA | 0.00 |
Director
|
$0 | $0 | $0 |
| PAUL PEREIRA | ARDELYX | 2.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL SOMERS | A.S. OF PEDIATR | 2.00 |
Director
|
$0 | $0 | $0 |
| PATRICE SMITH | SATELLITE HEALT | 2.00 |
Director
|
$0 | $0 | $0 |
| ROB BOMSTAD | RENAL HEALTHCAR | 2.00 |
Director
|
$0 | $0 | $0 |
| SARA FROELICH | AKEBIA THERAPEU | 2.00 |
Director
|
$0 | $0 | $0 |
| SCOTT TERRILLION | CARA THERAPEUTI | 2.00 |
Director
|
$0 | $0 | $0 |
| FRANCINE ATTRILL | US RENAL CARE | 2.00 |
Director
|
$0 | $0 | $0 |
| WADE DELK | NORTH AMERICAN | 2.00 |
Director
|
$0 | $0 | $0 |
| MAHESH KRISHAN | KCP CHAIR | 2.00 |
Officer
|
$0 | $0 | $0 |
| COLIN ROSKEY | Executive Dir. | 40.00 |
Officer
|
$0 | $0 | $0 |
| JOHN BUTLER | PAST CHAIR | 2.00 |
Officer
|
$0 | $0 | $0 |
| LORI HARTWELL | KCP TREASURER | 2.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $1,947,138 | $1,525,093 | $2,124,276 | $422,045 |
| 2022 | $1,473,804 | $1,946,424 | $959,763 | $-472,620 |
| 2021 | $1,130,158 | $1,463,128 | $1,501,158 | $-332,970 |
| 2020 | $2,005,874 | $1,492,979 | $1,295,758 | $512,895 |
Compare KIDNEY CARE PARTNERS INC CO FEDERAL HEALTH POLICY STRATEGIES with other nonprofits in District of Columbia and across the country.